ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Review

Recent advances in understanding neurotrophin signaling

[version 1; peer review: 2 approved]
PUBLISHED 28 Jul 2016
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

The nerve growth factor family of growth factors, collectively known as neurotrophins, are evolutionarily ancient regulators with an enormous range of biological functions. Reflecting this long history and functional diversity, mechanisms for cellular responses to neurotrophins are exceptionally complex. Neurotrophins signal through p75NTR, a member of the TNF receptor superfamily member, and through receptor tyrosine kinases (TrkA, TrkB, TrkC), often with opposite functional outcomes. The two classes of receptors are activated preferentially by proneurotrophins and mature processed neurotrophins, respectively. However, both receptor classes also possess neurotrophin-independent signaling functions. Signaling functions of p75NTR and Trk receptors are each influenced by the other class of receptors. This review focuses on the mechanisms responsible for the functional interplay between the two neurotrophin receptor signaling systems.

Keywords

75 kDa neurotrophin receptor, proneurotrophins, mature processed neurotrophins, Spätzle proteins,

Nerve growth factor (NGF) and its orthologs are collectively known as neurotrophins. Mammals have four neurotrophins – NGF, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin 4 (NT-4, also known as NT-4/5). Neurotrophins, functioning as homodimers, have a wide variety of functions in both neural and non-neural tissues, and they control adult physiology as well as embryonic development.

The 4 neurotrophins signal through three paralogous receptor tyrosine kinases (TrkA, TrkB and TrkC) and the 75 kDa neurotrophin receptor (p75NTR), which is a member of the death domain-containing receptor subgroup (so-called death receptors) of the TNF receptor superfamily. While p75NTR is activated by all four neurotrophins, the Trk receptors are more selective, as shown in the table.

Table 1. Ligand preferences of neurotrophin receptors.

Ligands listed in italic type have lower affinity and/or are less commonly important for receptor activation in vivo.

ReceptorLigand
p75NTRNGF, BDNF, NT3, NT4
TrkANGF, NT3
TrkBBDNF, NT4, NT3
TrkCNT3

The neurotrophin system is ancient, as orthologs of neurotrophins, p75NTR and Trks are found in invertebrates as diverse as sea urchins, mollusks and round worms1,2. Consequently, this signaling system has had half a billion years of evolution to develop extraordinary complexity. A goal of this review will be to capture the many levels of complexity of the neurotrophin receptor signaling system. Perversely, the entire signaling system has been lost in Caenorhabditis and Drosophila lineages, depriving investigators of convenient genetic systems to unravel the complexity of neurotrophin signaling.

Although neurotrophic Drosophila proteins have been referred to as neurotrophins, they are only distantly similar to neurotrophins of other invertebrate and vertebrate species, and they signal via toll-like receptors, rather than p75NTR or Trk-like receptors35. I prefer to refer to these neurotrophin-like cytokines by their original names, Spätzle and Spätzle-family proteins, rather than as neurotrophins, to avoid confusion.

It has been said that there is a yin and yang relationship between p75NTR and Trk receptors, because they often are co-expressed and function oppositely6. For example, TrkA signaling in sympathetic neurons promotes axon growth and neuronal survival, whereas p75NTR signaling promotes axon degeneration and neuronal cell death7. BDNF controls hippocampal neuronal synaptic plasticity, learning and memory with TrkB signaling promotes synaptic long term potentiation (LTP) and p75NTR signaling promoting long term depression (LTD)6. Functional interactions between the two receptor systems produce multiple levels of complexity, while several different mechanisms control the balance between the yin and the yang of neurotrophin signaling.

Like many biologically active polypeptides, neurotrophins are synthesized as precursors (pro-neurotrophins), which are cleaved to release an N-terminal prodomain peptide and a C-terminal mature neurotrophin. This cleavage event may occur either within the secretory pathway or following secretion, so that receptors may be exposed to both proneurotrophins and mature neurotrophins. Importantly, p75NTR binds both mature and proneurotrophins, and is more effectively activated by proneurotrophins, while only mature neurotrophins activate Trk receptors8,9. The enhanced action of proneurotrophins binding to p75NTR is dependent on association of p75NTR with sortilin or SorCS2, Vps10p-domain proteins which bind a conserved motif in proneurotrophin prodomains10,11.

The complexity of function that can be generated by these relationships is well illustrated by sympathetic neurons, which express TrkA and p75NTR, but not TrkB. For these neurons, proNGF, which activates p75NTR but not TrkA, promotes cell death. Mature NGF, which activates both p75NTR and TrkA, promotes cell survival. ProBDNF or mature BDNF promotes cell death, because these ligands bind p75NTR but not TrkA1214.

The canonical mode of signaling by Trk receptors is similar to signaling by other receptor tyrosine kinases. Neurotrophin binding promotes formation of Trk dimers, and induces trans-phosphorylation of Trk cytoplasmic domain tyrosine residues, initiating recruitment of signaling adapter proteins that foster signaling by ras/ERK1/2, PI3 kinase/Akt STAT and phospholipase Cγ pathways15. However, alternatively spliced forms of TrkB and TrkC (misleadingly known as truncated TrkB and truncated TrkC) lack a tyrosine kinase domain, but possess alternative cytoplasmic domain sequences that signal by less extensively characterized mechanisms16,17.

One feature of canonical signaling by Trk receptors that differs from many other receptor tyrosine kinases is the use of so-called signaling endosomes to achieve retrograde axonal signaling. For most receptor tyrosine kinases, ligand-mediated activation of the receptor leads to receptor endocytosis, followed either by lysosomal degradation of the receptor or recycling back to the cell surface. However, in many physiological scenarios, the survival and/or differentiated state of neurons is regulated by neurotrophins secreted by the target tissues those neurons innervate. In this context, endocytosis of the neurotrophin/Trk complex generates signaling endosomes, which undergo retrograde axonal transport, delivering the activated neurotrophin/receptor complex to the somatic compartment in order to permit control of nuclear transactivation of genes1821. The exquisite complexity associated with this mode of signaling is nicely illustrated by sympathetic neurons, where NT3 and NGF differently control axonal TrkA signaling functions because of differences in the pH-dependence for NT3 and NGF binding. Sympathetic axons encounter NT3 on the route to their target. NT3 activates TrkA and achieves local control of axonal growth cone dynamics, but does not engage signaling to the cell soma because NT3 dissociates from TrkA at the acidic pH within endosomes, causing TrkA receptors to recycle to the local plasma membrane without production of axonally transported signaling endosomes. In contrast, NGF/TrkA complexes remain intact as endosomes acidify, allowing TrkA to engage the motor systems that mediate retrograde axonal transport of TrkA-bearing endosomes22.

p75NTR signaling shares several features with other death receptors. A juxta-membrane region of the cytoplasmic domain binds TRAF6, which engages signaling pathways leading to activation of NF-κB and JNK23,24. The death domain interacts with RhoGDI, which controls RhoA activation, and RIP2 kinase, which contributes to NF-κB and JNK activation25. Neurotrophin binding to p75NTR inhibits RhoA activation26, while enhancing JNK activation27,28. However, TRAF6, RhoGDI and RIP2 are only a few of the bewildering array of p75NTR-binding signaling adapter proteins that have been reported to mediate p75NTR signaling. Other notable examples include NRIF, which promotes JNK activation28,29, MAGE proteins including NRAGE, which promote Rac1 and JNK activation30, and Bex1, which negatively affects NF-κB signaling31,32. Further, p75NTR has been reported to influence glucose uptake in adipocytes via Glut4 by directly binding the trafficking regulators Rab5 and Rab3133, to controls energy expenditure in obese mice on a high-fat diet by inhibiting cAMP signaling in adipocytes via direct association of p75NTR with protein kinase A34, and to promote fibrinolysis in nerve injury and lung fibrosis by binding and enhancing the cAMP degradative activity of phosphodiesterase PDE4A4/535.

One feature of p75NTR function is unique, so far, among known receptors. A cysteinyl residue in the membrane spanning domain of p75NTR forms a disulfide bond, within the lipid bilayer, creating a covalently linked-dimeric form of p75NTR, and this covalent linkage is required for neurotrophin-dependent JNK activation, but not inhibition of RhoA activity36. Mutation of the single cysteinyl residue required to form this disulfide bond eliminates p75NTR-dependent death signaling in neurons in vitro and in vivo37. A physiologically occurring disulfide bond within a lipid bilayer has never been described previously in any membrane protein, and the mechanism by which a disulfide forms in such an unusual environment is unclear. However, our unpublished evidence (Leslayann Schecterson and Mark Bothwell) demonstrates that this linkage forms within 2 minutes when cells are exposed to minute concentrations of hydrogen peroxide, indicating that oxidative stress may control p75NTR signaling, as we have reported previously38.

A detailed model, illustrated in Figure 1, has recently been proposed for death domain-mediated p75NTR signaling25. In the absence of bound neurotrophin, the death domains of p75NTR dimers form a homodimeric complex. The RhoGDI binding site is not occluded by this interaction, so non-liganded p75NTR engages RhoGDI-dependent RhoA activation. Binding of a neurotrophin dimer to the extracellular domain of a disulfide-linked p75NTR dimer, causes a scissoring action (or more accurately a snail-tong action) around the disulfide pivot-point, separating originally juxtaposed death domains, and allowing access of RIP2 to a binding site that was previously partially occluded by the death domain/death domain interaction. The RIP2 binding site partially overlaps with the RhoGDI binding site, so RIP2 binding displaces RhoGDI, initiating JNK activation and terminating RhoA activation.

226116ca-4736-4fc7-849a-44896dfaa2f0_figure1.gif

Figure 1. p75NTR Signaling.

In absence of ligand, death domains of disulfide-linked p75NTR dimer bind RhoGDI, promoting formation of active GTP-bound RhoA. Binding of neurotrophin or proneurotrophin causes a scissoring action of the dimer, displacing the death domains laterally and allowing RIP2 to bind the death domains. RIP2 promotes activation of JNK and NF-κB and by displacing RhoGDI, terminates RhoA activation.

Challenging the elegant simplicity of this model, an element of controversy has been introduced by the suggestion that the p75NTR oligomer observed on non-reducing SDS gels is a trimer, rather than a dimer39,40. This conclusion relies primarily on the ratio of the apparent molecular weights of p75NTR monomer and oligomer on non-reducing SDS gels. A caveat for such analysis is that the theoretical basis for the proportionality of electrophoretic mobility and protein mass on SDS gels assumes that SDS-induced denaturation fully unfolds the protein and causes the protein to form linear structures with length proportional to mass41. This assumption does not apply to p75NTR, which contains multiple intra-chain disulfide linkages if disulfide bonds are not reduced before electrophoresis. p75NTR function as a trimer is inconsistent with X-ray crystallographic and/or NMR generated three-dimensional structures indicating that the extracellular domain of p75NTR42, the death domain region of the intracellular domain of p75NTR25, and the membrane spanning domain of p75NTR43 each forms dimers, not trimers. Application of emerging technologies such as cryo-EM will be required to provide definitive evidence about the stoichiometry of intact p75NTR.

Although the reader may think that the preceding account is already quite complicated enough, another mode of p75NTR signaling, and its manner of influence by Trk receptors, provides substantial additional complexity, as summarized in Figure 2. Soon after the discovery of Trk receptors, it was reported that p75NTR/Trk heterodimeric complexes could form, enhancing the affinity of NGF binding to TrkA44, and causing TrkA and TrkB to be less effectively activated by NT315. Although the physiological importance of these p75NTR effects on Trk signaling remain uncertain, recently Trk-dependent effects on p75NTR signaling have emerged that seem likely to have physiological relevance. p75NTR has an alternative signaling pathway that resembles the mode of signaling of Notch. ADAM10 or ADAM17-dependent cleavage of the p75NTR extracellular domain near the membrane, followed by γ-secretase mediated release of the intracellular domain into the cytoplasm, fosters signaling4547. Interestingly, a similar mode of signaling by another TNF receptor superfamily member, TNFR1, has been described recently48. Differential cleavage of p75NTR in different types of neurons produced different signaling outcomes49. Signaling effects attributed to the mobilized p75NTR intracellular domain include nuclear accumulation of NRIF47, association with the ubiquitin ligase siah2 controlling degradation of the transcription factor Hif1α50, and association with nuclear pore complexes promoting nuclear uptake of the SMAD2 transcription factor51. Neurotrophin binding to p75NTR does not directly influence the rate of ADAM protease-mediated cleavage of p75NTR45,46,52 although signaling pathways initiated by neurotrophin binding may enhance p75NTR cleavage many hours after neurotrophin exposure47. Interestingly, activation of Trk receptors promotes the p75NTR cleavage pathway45,53.

226116ca-4736-4fc7-849a-44896dfaa2f0_figure2.gif

Figure 2. Cell death and cell survival signaling by p75NTR and Trk receptors.

(Above) Proneurotrophins interact preferentially with p75NTR, promoting JNK dependent caspase activation and cell death. Sequential cleavage of p75NTR by ADAM10/17 and γ-secretase, allowing cytoplasmic mobilization of the intracellular domain of p75NTR, may also promote cell death, by a mechanism that is only indirectly promoted by neurotrophins. Non-liganded Trk A and TrkC promote cell death by a mechanism that implicates the p75NTR cleavage pathway. (Below) Mature neurotrophins preferentially activate Trk receptors, in a manner that may be enhanced by p75NTR, particularly for TrkA. Neurotrophin activation of Trks promotes cell survival.

It remains to be determined definitively whether Trk activity represents a major mode of regulation of the p75NTR cleavage signaling pathways in vivo. However, the recently reported function of TrkA and TrkC as dependence receptors may reflect a consequence of this mode of interaction. Dependence receptors are receptors that signal constitutively until ligand binding terminates signaling. Although each of the three Trk paralogs was originally found to promote neuronal survival, in some neuronal populations, neurotrophin-independent effects of TrkA and TrkC were reported to promote neuronal cell death, and the cleavage mediated signaling pathway of p75NTR has been implicated as a mediator of this effect54,55.

The foregoing paragraphs have focused on neurotrophin-dependent signaling by neurotrophin receptors, but other ligands importantly engage signaling by both Trk and p75NTR receptors. For Trk receptors, the most common mechanism for signaling in response to non-neurotrophin ligands involves receptor transactivation, most commonly of TrkB. A variety of G protein-coupled receptors, including PACAP and A2a adenosine receptors, activate TrkB via Gsα-dependent activation of Src family kinases (commonly Fyn in neural tissue)56,57. In the context of embryonic cerebral cortex, where developing neurons express abundant TrkB receptors, EGF-dependent activation of EGF receptors engages Src-dependent TrkB activation58. Src family kinase-mediated Trk transactivation also is induced by ligand-dependent activation of Low-density lipoprotein receptor-related protein 1 (LRP1)59, and by zinc ion, which is co-released during glutamatergic neurotransmission60,61. One interesting feature of transactivation of TrkB is that activation commonly occurs in the ERGIC or Golgi compartments, rather than at the cell surface. Signaling from intracellular sites may not be functionally equivalent to signaling from the plasma membrane. For example, PACAP-dependent transactivation of TrkB in cultured hippocampal neurons, by coupling to pathways that otherwise control Golgi dynamics during cell division, induces fragmentation of the Golgi apparatus and alters Golgi-dependent processing of other membrane proteins62.

A variety of modes of neurotrophin-independent activation of p75NTR have been reported. p75NTR is one of several receptors that bind Aβ peptide and putatively engage in pathogenic signaling in Alzheimer’s disease40,63. Other scenarios in which non-neurotrophin ligands control p75NTR signaling involve association of p75NTR with co-receptors that bind the activating ligand. Axon--repellant signaling by CNS myelin proteins such as Nogo, MAG, or OMgp, mediated by association of NgR1 with p75NTR,64,65 or the p75NTR homolog, Troy66 while ephrin-A/p75NTR complexes have been implicated as mediators of EPH-dependent reverse signaling67.

Although great progress has been made in elucidating the signaling pathways employed by neurotrophin receptors, a systems level understanding of how these signaling pathways are selectively engaged in vivo is sadly lacking. It is a daunting task to understand how this extraordinarily rich palette of neurotrophin receptor signaling modalities is controlled physiologically.

Abbreviations

BDNF, brain-derived neurotrophic factor; EGF, epidermal growth factor; ERGIC, endoplasmic reticulum Golgi intermediate compartment; JNK, Jun kinase; MAG, myelin associated glycoprotein; NGF, nerve growth factor; NMR, nuclear magnetic resonance; NT3, neurotrophin 3; NT4, neurotrophin 4; OMgp, oligomyelin glycoprotein; p75NTR, 75 kDa neurotrophin receptor; RhoGDI, Rho GDP dissociation inhibitor; TNF, tumor necrosis factor; Trk, tropomyosin related kinase.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 28 Jul 2016
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Bothwell M. Recent advances in understanding neurotrophin signaling [version 1; peer review: 2 approved] F1000Research 2016, 5(F1000 Faculty Rev):1885 (https://doi.org/10.12688/f1000research.8434.1)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 28 Jul 2016
Views
0
Cite
Reviewer Report 28 Jul 2016
Bruce Carter, Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN, USA;  Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, TN, USA 
Approved
VIEWS 0
I confirm that I have read this submission and believe that I have an ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Carter B. Reviewer Report For: Recent advances in understanding neurotrophin signaling [version 1; peer review: 2 approved]. F1000Research 2016, 5(F1000 Faculty Rev):1885 (https://doi.org/10.5256/f1000research.9081.r14862)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
0
Cite
Reviewer Report 28 Jul 2016
Philip Barker, Biology Unit, University of British Columbia, Kelowna, British Columbia, Canada 
Approved
VIEWS 0
I confirm that I have read this submission and believe that I have an ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Barker P. Reviewer Report For: Recent advances in understanding neurotrophin signaling [version 1; peer review: 2 approved]. F1000Research 2016, 5(F1000 Faculty Rev):1885 (https://doi.org/10.5256/f1000research.9081.r14861)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 28 Jul 2016
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.